CA2014948A1 - Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine - Google Patents

Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine

Info

Publication number
CA2014948A1
CA2014948A1 CA2014948A CA2014948A CA2014948A1 CA 2014948 A1 CA2014948 A1 CA 2014948A1 CA 2014948 A CA2014948 A CA 2014948A CA 2014948 A CA2014948 A CA 2014948A CA 2014948 A1 CA2014948 A1 CA 2014948A1
Authority
CA
Canada
Prior art keywords
genes
human macif
macif activity
protein
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2014948A
Other languages
English (en)
Other versions
CA2014948C (fr
Inventor
Motowo Tomita
Yuji Sugita
Toshiyuki Takemoto
Kiyoshi Furuichi
Makoto Takayama
Ko Yasukawa
Shinya Yano
Noboru Yamaji
Katsuhisa Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of CA2014948A1 publication Critical patent/CA2014948A1/fr
Application granted granted Critical
Publication of CA2014948C publication Critical patent/CA2014948C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA002014948A 1989-04-21 1990-04-19 Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine Expired - Fee Related CA2014948C (fr)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP10308889 1989-04-21
JPHEI.1-103088 1989-04-21
JPHEI.1-179933 1989-07-12
JP17993389 1989-07-12
JP23098389 1989-09-06
JPHEI.1-230983 1989-09-06
JPHEI.1-238246 1989-09-13
JP23824689 1989-09-13
JP24781889 1989-09-21
JPHEI.1-247818 1989-09-21
JP28119789 1989-10-27
JPHEI.1-281197 1989-10-27

Publications (2)

Publication Number Publication Date
CA2014948A1 true CA2014948A1 (fr) 1990-10-21
CA2014948C CA2014948C (fr) 2000-12-12

Family

ID=27552152

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014948A Expired - Fee Related CA2014948C (fr) 1989-04-21 1990-04-19 Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine

Country Status (12)

Country Link
US (1) US5532339A (fr)
EP (2) EP0672683B1 (fr)
JP (1) JP2828148B2 (fr)
KR (1) KR0150000B1 (fr)
AT (2) ATE132900T1 (fr)
AU (1) AU640643B2 (fr)
CA (1) CA2014948C (fr)
DE (2) DE69024693T2 (fr)
DK (1) DK0394035T3 (fr)
ES (1) ES2084658T3 (fr)
GR (1) GR3019347T3 (fr)
IE (2) IE74168B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795736A (en) * 1989-04-21 1998-08-18 Yamanouchi Pharmaceutical Co., Ltd. Genes coding for a protein having human MACIF activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59
AU6015696A (en) * 1995-06-16 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Modified polypeptide, dna encoding the same, transformant, and medicinal composition containing the polypeptide
US7166568B1 (en) 1998-02-09 2007-01-23 Oklahoma Medical Research Foundation Compositions and methods to inhibit formation of the C5b-9 complex of complement
WO2001010908A1 (fr) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, membre de la famille de supergenes recepteurs du tnf
US6835545B2 (en) 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
US7439330B2 (en) 2000-05-08 2008-10-21 President And Fellows Of Harvard College Anti-glycated CD59 antibodies and uses thereof
CN1325889A (zh) * 2000-05-26 2001-12-12 上海博德基因开发有限公司 一种新的多肽——人Kazal型抑制因子11和编码这种多肽的多核苷酸
US7833725B2 (en) 2005-01-06 2010-11-16 President And Fellows Of Harvard College Mass spectrometric methods and products
AU2015202046B2 (en) * 2008-02-15 2017-06-29 Tufts University A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
CA2843684A1 (fr) * 2010-08-13 2012-02-16 Tufts University Compositions, trousses et methodes de traitement de la degenerescence maculaire au moyen de la proteine cd59 soluble independante de la membrane
US9068006B2 (en) 2010-08-25 2015-06-30 President And Fellows Of Harvard College Glycated CD59 peptides, their preparation, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
US5179198A (en) * 1988-07-11 1993-01-12 Hidechika Okada Glycoprotein and gene coding therefor
US4935494A (en) * 1988-11-15 1990-06-19 City Of Hope C-terminal peptide and protein sequencing

Also Published As

Publication number Publication date
ATE202570T1 (de) 2001-07-15
JP2828148B2 (ja) 1998-11-25
EP0672683A1 (fr) 1995-09-20
KR0150000B1 (ko) 1998-08-17
EP0394035A2 (fr) 1990-10-24
EP0672683B1 (fr) 2001-06-27
CA2014948C (fr) 2000-12-12
IE960874L (en) 1990-10-21
DE69024693T2 (de) 1996-07-11
JPH03201985A (ja) 1991-09-03
KR900016465A (ko) 1990-11-13
DE69033756D1 (de) 2001-08-02
IE901426L (en) 1990-10-21
AU640643B2 (en) 1993-09-02
GR3019347T3 (en) 1996-06-30
ATE132900T1 (de) 1996-01-15
DK0394035T3 (da) 1996-05-13
DE69033756T2 (de) 2002-04-18
DE69024693D1 (de) 1996-02-22
ES2084658T3 (es) 1996-05-16
US5532339A (en) 1996-07-02
EP0394035A3 (fr) 1991-08-21
EP0394035B1 (fr) 1996-01-10
IE74168B1 (en) 1997-07-02
AU5372690A (en) 1990-11-08

Similar Documents

Publication Publication Date Title
DE68912268D1 (en) Elastomere polypeptide als vaskulare prothesematerialien.
GR3017451T3 (en) Peptides having T cell helper activity.
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
AU3228789A (en) Biologically active proteins
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
AU1470292A (en) Stabilized factor viii preparations
AU2385988A (en) Polypeptides with fibronectin activity
AU4224889A (en) Synthetic, anti-complement protein and the gene encoding same
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
IL95057A (en) Recombinant gene coding for a protein possessing urate oxidase activity
IL90209A0 (en) Dna coding for a hiv-1 protein,the protein produced and its use
CA2014948A1 (fr) Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine
AU3630189A (en) Novel polypeptides with an anticoagulant activity
AU6312994A (en) A gene coding for a protein regulating aureobasidin sensitivity
AU3414689A (en) Therapeutic peptides
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
AU676277B2 (en) DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
AU623749B2 (en) Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe
AU5627090A (en) A novel alpha-amylase-pullulanase enzyme, a dna sequence coding the same, a recombinant dna molecule and a recombinant clone expressing the enzyme
AU4824090A (en) Promoter, plasmid containing the same, and recombinant avipoxvirus
ZA903833B (en) Saf polypeptide,gene coating therefor
AU5071390A (en) Dna encoding ovine-active, growth-hormone-receptor-binding, lactogenic protein
IE873131L (en) Recombinant protein expression.
SU1617417A1 (ru) Иctoчhиk пиtahия пoctoяhhoгo haпpяжehия

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed